Total Funding
77
49
Total FundingVenture - Series Unknown raised
Growth Score 77 in past quarter
-13 pts
Heat Score 49 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
42692
32 Biosciences is a biotechnology company at the forefront of gut microbiome medicine, focusing on both diagnostics and therapeutics.
- John Alverdy: Founder
- Peter Farmakis: Chairman & CEO
About the Company
32 Biosciences is a healthcare company dedicated to advancing gut microbiome medicine. The company’s mission is to revolutionize healthcare by defining, diagnosing, and restoring the functional health of the gut microbiome to prevent and treat chronic diseases, thereby improving health span and longevity.